1569646-00-9

Upstream product

• 769-56-2 4,6-dibromobenzo[c][1,2,5]oxadiazole 
• 405-66-3 (4-Fluoro-benzyl)-methyl-amine 

Downstream Products

• 1569651-33-7 C₂₂H₁₈FN₃O₂ 
• 1569645-94-8 C₂₂H₁₇F₄N₃O₂ 
• 1569646-26-9 C₁₆H₁₃F₄N₃O₂ 
• 1569646-60-1 C₁₉H₁₄F₇N₃O₂ 
• 1569646-65-6 C₁₈H₁₆FN₃O₃ 
• 1569647-30-8 C₁₈H₁₄FN₃O₃ 
• 1569647-35-3 C₁₄H₁₁FIN₃O 
• 1569647-39-7 C₁₇H₁₆FN₃O₂ 
• 1569648-41-4 C₁₇H₁₅F₄N₃O₂ 
• 1569648-46-9 C₁₆H₁₁F₄N₃O₂ 
• 1569648-51-6 C₁₆H₁₄FN₃O₂ 
• 1569648-83-4 C₁₇H₁₈FN₃O₂ 
• 1569648-93-6 C₁₇H₁₈FN₃O₂ 
• 1569649-15-5 C₁₈H₁₈FN₃O₂ 

Relevant academic research and scientific papers

ANTI-AMYLOID COMPOUNDS CONTAINING BENZOFURAZAN

In general, among other things, compounds of Formula I are provided: in which R11 is e.g., 4-(pyrrolidin-1-yl)piperidin-1-yl, N-methyl-3-(pyrrolidin-1-yl)propan-1-amino, N1,N1,N3-trimethylpropane-1,3-diamino, N,N-dimethylpiperidin-4-amino, 3-(pyrrolidin-1-ylmethyl)azetidin-1-yl, 3-(pyrrolidin-1-ylmethanon)azetidin-1-yl, or 3-(morpholin-1-ylmethyl)azetidin-1-yl; R13 is, e.g., phenyl optionally substituted with one or more substituents; and R12 and R14 are each independently hydrogen or alkyl. Methods of treatment are also provided.

BENZOFURAZAN ANTI-AMYLOID COMPOUNDS AND METHODS

In general, among other things, compounds of Formula I are provided: in which R11 is selected from the group consisting of benzylamino, N-methylbenzylamino, morpholino, thiomorpholino, pyrrolidino, etc.; R13 is selected from the group consisting of 3-(1-ethanol-2-yl)phenyl, 3-(1-ol-2,2,2-trifluoroethan-2-yl)phenyl, 2-(1-ol-2,2,2-trifluoroethan-2- yl)phenyl, etc.; and R12 and R14 are each independently hydrogen or alkyl. Methods of treatment are also provided.